This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
3 days in-person. 3 days virtually.
March 20–22, 2023 | Basel, SwitzerlandMarch 28–30, 2023 | Digital

Fabian Berkemeier
Managing Director at IGES Institut GmbH


Fabian Berkemeier studied economic engineering with a specialization on health technology at the Technical University of Berlin and the KTH Royal Institute of Technology (Stockholm, Sweden). Fabian joined IGES in 2015 and his work focuses on strategic market access consulting incorporating health outcomes, health economics, policy, and stakeholder engagement. In addition, Fabian is responsible for the conception and execution of Real World Evidence studies as well as the planning and management of national and international product launches.

Prior to joining IGES, Fabian collected experience in the fields of market access (top 10 pharmaceutical manufacturer) and health politics (German ministry of health). Parallel to his work for IGES Institute, Fabian conducted research on the effects of drug regulation at Berlin Institute of Technology and the University of California Berkeley.

Fabian Berkemeier's Network

Agenda Sessions

  • HTA procedures in the European Union are being harmonized – the industry’s view.

  • HTA procedures in the European Union are being harmonized – EUNetHTA’s view.